Effect of antiplatelet and anticoagulant medication use on injury severity and mortality in patients with traumatic brain injury treated in the intensive care unit.
Anticoagulant medication
Antiplatelet medication
Computed tomography
Intensive care
Traumatic brain injury
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
received:
26
07
2023
accepted:
17
10
2023
medline:
1
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
aheadofprint
Résumé
Antiplatelet and anticoagulant medication are increasingly common and can increase the risks of morbidity and mortality in traumatic brain injury (TBI) patients. Our study aimed to quantify the association of antiplatelet or anticoagulant use in intensive care unit (ICU)-treated TBI patients with 1-year mortality and head CT findings. We conducted a retrospective, multicenter observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted to four university hospital ICUs during 2003-2013. The patients were followed up until the end of 2016. The national drug reimbursement database provided information on prescribed medication for our study. We used multivariable logistic regression models to assess the association between TBI severity, prescribed antiplatelet and anticoagulant medication, and their association with 1-year mortality. Of 3031 patients, 128 (4%) had antiplatelet and 342 (11%) anticoagulant medication before their TBI. Clopidogrel (2%) and warfarin (9%) were the most common antiplatelets and anticoagulants. Three patients had direct oral anticoagulant (DOAC) medication. The median age was higher among antiplatelet/anticoagulant users than in non-users (70 years vs. 52 years, p < 0.001), and their head CT findings were more severe (median Helsinki CT score 3 vs. 2, p < 0.05). In multivariable analysis, antiplatelets (OR 1.62, 95% CI 1.02-2.58) and anticoagulants (OR 1.43, 95% CI 1.06-1.94) were independently associated with higher odds of 1-year mortality. In a sensitivity analysis including only patients over 70, antiplatelets (OR 2.28, 95% CI 1.16-4.22) and anticoagulants (1.50, 95% CI 0.97-2.32) were associated with an increased risk of 1-year mortality. Both antiplatelet and anticoagulant use before TBI were risk factors in our study for 1-year mortality. Antiplatelet and anticoagulation medication users had a higher radiological intracranial injury burden than non-users defined by the Helsinki CT score. Further investigation on the effect of DOACs on mortality should be done in ICU-treated TBI patients.
Sections du résumé
BACKGROUND
BACKGROUND
Antiplatelet and anticoagulant medication are increasingly common and can increase the risks of morbidity and mortality in traumatic brain injury (TBI) patients. Our study aimed to quantify the association of antiplatelet or anticoagulant use in intensive care unit (ICU)-treated TBI patients with 1-year mortality and head CT findings.
METHOD
METHODS
We conducted a retrospective, multicenter observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted to four university hospital ICUs during 2003-2013. The patients were followed up until the end of 2016. The national drug reimbursement database provided information on prescribed medication for our study. We used multivariable logistic regression models to assess the association between TBI severity, prescribed antiplatelet and anticoagulant medication, and their association with 1-year mortality.
RESULTS
RESULTS
Of 3031 patients, 128 (4%) had antiplatelet and 342 (11%) anticoagulant medication before their TBI. Clopidogrel (2%) and warfarin (9%) were the most common antiplatelets and anticoagulants. Three patients had direct oral anticoagulant (DOAC) medication. The median age was higher among antiplatelet/anticoagulant users than in non-users (70 years vs. 52 years, p < 0.001), and their head CT findings were more severe (median Helsinki CT score 3 vs. 2, p < 0.05). In multivariable analysis, antiplatelets (OR 1.62, 95% CI 1.02-2.58) and anticoagulants (OR 1.43, 95% CI 1.06-1.94) were independently associated with higher odds of 1-year mortality. In a sensitivity analysis including only patients over 70, antiplatelets (OR 2.28, 95% CI 1.16-4.22) and anticoagulants (1.50, 95% CI 0.97-2.32) were associated with an increased risk of 1-year mortality.
CONCLUSIONS
CONCLUSIONS
Both antiplatelet and anticoagulant use before TBI were risk factors in our study for 1-year mortality. Antiplatelet and anticoagulation medication users had a higher radiological intracranial injury burden than non-users defined by the Helsinki CT score. Further investigation on the effect of DOACs on mortality should be done in ICU-treated TBI patients.
Identifiants
pubmed: 37910309
doi: 10.1007/s00701-023-05850-w
pii: 10.1007/s00701-023-05850-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Helsingin ja Uudenmaan Sairaanhoitopiiri
ID : VTR TYH2018227
Organisme : Helsingin ja Uudenmaan Sairaanhoitopiiri
ID : VTR TYH2023330
Informations de copyright
© 2023. The Author(s).
Références
Apostolaki-Hansson T, Ullberg T, Norrving B, Petersson J (2022) Patient factors associated with receiving reversal therapy in oral anticoagulant-related intracerebral hemorrhage. Acta Neurol Scand 146(5):590–597
doi: 10.1111/ane.13685
pubmed: 35974708
pmcid: 9805025
Batchelor JS, Grayson A (2013) A meta-analysis to determine the effect of preinjury antiplatelet agents on mortality in patients with blunt head trauma. Br J Neurosurg 27(1):12–18
doi: 10.3109/02688697.2012.705361
pubmed: 22900511
Caldeira D, Alves da Silva P, Pinto FJ (2023) Clinical outcomes of anticoagulated patients with atrial fibrillation after falls or head injury: insights from RE-LY. Stroke. https://doi.org/10.1161/STROKEAHA.122.041628
doi: 10.1161/STROKEAHA.122.041628
pubmed: 37144391
Cull JD, Sakai LM, Sabir I et al (2015) Outcomes in traumatic brain injury for patients presenting on antiplatelet therapy. Am Surg 81(2):128–132
doi: 10.1177/000313481508100223
pubmed: 25642873
Dunham CM, Hoffman DA, Huang GS, Omert LA, Gemmel DJ, Merrell R (2014) Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study. Plos One 9(10):e109473
doi: 10.1371/journal.pone.0109473
pubmed: 25279785
pmcid: 4184859
Franko J, Kish KJ, O’Connell BG, Subramanian S, Yuschak JV (2006) Advanced age and preinjury warfarin anticoagulation increase the risk of mortality after head trauma. J Trauma Acute Care Surg 61(1):107
doi: 10.1097/01.ta.0000224220.89528.fc
Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857
doi: 10.7326/0003-4819-146-12-200706190-00007
pubmed: 17577005
Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC (2007) The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 22(5):341–353
doi: 10.3233/NRE-2007-22502
pubmed: 18162698
Ibáñez L, Sabaté M, Vidal X et al (2019) Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): a cross-national drug utilization study. Br J Clin Pharmacol 85(11):2524–2539
doi: 10.1111/bcp.14071
pubmed: 31318059
pmcid: 6848911
Jennett B (1996) Epidemiology of head injury. J Neurol Neurosurg Psychiatry 60(4):362–369
doi: 10.1136/jnnp.60.4.362
pubmed: 8774396
pmcid: 1073884
Jones K, Sharp C, Mangram AJ, Dunn EL (2006) The effects of preinjury clopidogrel use on older trauma patients with head injuries. Am J Surg 192(6):743–745
doi: 10.1016/j.amjsurg.2006.08.037
pubmed: 17161086
Joseph B, Pandit V, Aziz H et al (2014) Clinical outcomes in traumatic brain injury patients on preinjury clopidogrel: a prospective analysis. J Trauma Acute Care Surg 76(3):817–820
doi: 10.1097/TA.0b013e3182aafcf0
pubmed: 24553554
Keene AR, Cullen DJ (1983) Therapeutic Intervention Scoring System: update 1983. Crit Care Med 11(1):1–3
doi: 10.1097/00003246-198301000-00001
pubmed: 6848305
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818–829
doi: 10.1097/00003246-198510000-00009
pubmed: 3928249
Le Gall J-R, Lemeshow S, Saulnier F (1993) Simplified Acute Physiology Score (SAPS II) based on a European / North American multicenter study. JAMA 270:2957–2963
doi: 10.1001/jama.1993.03510240069035
pubmed: 8254858
Lehto M, Halminen O, Mustonen P et al (2022) The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics. Eur J Epidemiol 37(1):95–102
doi: 10.1007/s10654-021-00812-x
pubmed: 34985732
pmcid: 8791884
Levy JH, Douketis J, Weitz JI (2018) Reversal agents for non-vitamin K antagonist oral anticoagulants. Nat Rev Cardiol 15(5):273–281
doi: 10.1038/nrcardio.2017.223
pubmed: 29345686
Lim XT, Ang E, Lee ZX, Hajibandeh S, Hajibandeh S (2021) Prognostic significance of preinjury anticoagulation in patients with traumatic brain injury: a systematic review and meta-analysis. J Trauma Acute Care Surg 90(1):191
doi: 10.1097/TA.0000000000002976
pubmed: 33048909
Maegele M, Schöchl H, Menovsky T, Maréchal H, Marklund N, Buki A, Stanworth S (2017) Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol 16(8):630–647
doi: 10.1016/S1474-4422(17)30197-7
pubmed: 28721927
Marshall LF, Marshall SB, Klauber MR, Clark MB (1991) A new classification of head injury based on computerized tomography. J Neurosurg 75(11):S14–S22
doi: 10.3171/sup.1991.75.1s.0s14
Mathieu F, Güting H, Gravesteijn B et al (2020) Impact of antithrombotic agents on radiological lesion progression in acute traumatic brain injury: a CENTER-TBI propensity-matched cohort analysis. J Neurotrauma 37(19):2069–2080
doi: 10.1089/neu.2019.6911
pubmed: 32312149
Nederpelt CJ, van der Aalst SJM, Rosenthal MG, Krijnen P, Huisman MV, Peul WC, Schipper IB (2020) Consequences of pre-injury utilization of direct oral anticoagulants in patients with traumatic brain injury: a systematic review and meta-analysis. J Trauma Acute Care Surg 88(1):186
doi: 10.1097/TA.0000000000002518
pubmed: 31688828
Nelson DW, Nyström H, MacCallum RM, Thornquist B, Lilja A, Bellander B-M, Rudehill A, Wanecek M, Weitzberg E (2010) Extended analysis of early computed tomography scans of traumatic brain injured patients and relations to outcome. J Neurotrauma 27(1):51–64
doi: 10.1089/neu.2009.0986
pubmed: 19698072
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
doi: 10.1097/00000421-198212000-00014
pubmed: 7165009
Ott MM, Eriksson E, Vanderkolk W, Christianson D, Davis A, Scholten D (2010) Antiplatelet and anticoagulation therapies do not increase mortality in the absence of traumatic brain injury. J Trauma Acute Care Surg 68(3):560
doi: 10.1097/TA.0b013e3181ad6600
Perel P, Roberts I, Bouamra O, Woodford M, Mooney J, Lecky F (2009) Intracranial bleeding in patients with traumatic brain injury: a prognostic study. BMC Emerg Med 9(1):15
doi: 10.1186/1471-227X-9-15
pubmed: 19650902
pmcid: 2735732
Posti JP, Ruuskanen JO, Sipilä JOT, Luoto TM, Rautava P, Kytö V (2022) Impact of oral anticoagulation and adenosine diphosphate inhibitor therapies on short-term outcome of traumatic brain injury. Neurology 99(11):e1122–e1130
doi: 10.1212/WNL.0000000000200834
pubmed: 35764401
Raj R, Bendel S, Reinikainen M et al (2018) Temporal trends in healthcare costs and outcome following ICU admission after traumatic brain injury. Crit Care Med 46(4):e302–e309
doi: 10.1097/CCM.0000000000002959
pubmed: 29293155
pmcid: 5865506
Raj R, Siironen J, Skrifvars MB, Hernesniemi J, Kivisaari R (2014) Predicting outcome in traumatic brain injury: development of a novel computerized tomography classification system (Helsinki Computerized Tomography Score). Neurosurgery 75(6):632–646
doi: 10.1227/NEU.0000000000000533
pubmed: 25181434
Reinikainen M, Mussalo P, Hovilehto S, Uusaro A, Varpula T, Kari A, Pettilä V, Finnish Intensive Care Consortium (2012) Association of automated data collection and data completeness with outcomes of intensive care. A new customised model for outcome prediction. Acta Anaesthesiol Scand 56(9):1114–1122
doi: 10.1111/j.1399-6576.2012.02669.x
pubmed: 22384799
Roozenbeek B, Maas AIR, Menon DK (2013) Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol 9(4):231–236
doi: 10.1038/nrneurol.2013.22
pubmed: 23443846
Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. The Lancet 383(9921):955–962
doi: 10.1016/S0140-6736(13)62343-0
Spektor S, Agus S, Merkin V, Constantini S (2003) Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate head injury: a prospective study. J Neurosurg 99(4):661–665
doi: 10.3171/jns.2003.99.4.0661
pubmed: 14567600
Thelin EP, Nelson DW, Vehviläinen J, Nyström H, Kivisaari R, Siironen J, Svensson M, Skrifvars MB, Bellander B-M, Raj R (2017) Evaluation of novel computerized tomography scoring systems in human traumatic brain injury: an observational, multicenter study. Plos Med 14(8):e1002368
doi: 10.1371/journal.pmed.1002368
pubmed: 28771476
pmcid: 5542385
Vehviläinen J, Skrifvars M, Reinikainen M, Bendel S, Laitio R, Hoppu S, Ala-Kokko T, Siironen J, Raj R (2022) External validation of the NeuroImaging Radiological Interpretation System and Helsinki computed tomography score for mortality prediction in patients with traumatic brain injury treated in the intensive care unit: a Finnish Intensive Care Consortium study. Acta Neurochir (Wien) 164(10):2709–2717
doi: 10.1007/s00701-022-05353-0
pubmed: 36050580
Wasmer K, Eckardt L, Breithardt G (2017) Predisposing factors for atrial fibrillation in the elderly. J Geriatr Cardiol JGC 14(3):179–184
pubmed: 28592961
Wintermark M, Li Y, Ding VY, Xu Y, Jiang B, Ball RL, Zeineh M, Gean A, Sanelli P (2018) Neuroimaging Radiological Interpretation System for acute traumatic brain injury. J Neurotrauma 35(22):2665–2672
doi: 10.1089/neu.2017.5311
pubmed: 29665763
Yang C, Lang L, He Z, Hui J, Jiang J, Gao G, Feng J (2022) Epidemiological characteristics of older patients with traumatic brain injury in China. J Neurotrauma 39(11–12):850–859
doi: 10.1089/neu.2021.0275
pubmed: 35171687
Zhou B, Ding VY, Li Y, Ball RL, Jiang B, Zhu G, Boothroyd D, Zeineh M, Gean A, Wintermark M (2019) Validation of the neuroimaging radiological interpretation system for acute traumatic brain injury. J Comput Assist Tomogr 43(5):690–696
doi: 10.1097/RCT.0000000000000913
pubmed: 31490891